Evidence map›Paper›PMID 41126332›Full record

ArticleInfectious diseases of poverty2025

Burden of asymptomatic malaria in adult sub-Saharan migrants attending an outpatient clinic in Rome from February 2024 to January 2025.

Francesca Faraglia, Serena Vita, Dimitra Kontogiannis, Tommaso Ascoli Bartoli, Silvia Rosati, Nazario Bevilacqua, Gaetano Maffongelli, Angela Corpolongo, Barbara Bartolini, Antonella Vulcano and 4 more

Abstract read
In one paragraph

Article in Infectious diseases of poverty, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Francesca Faraglia *National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Via Portuense 292, 00149, Rome, Italy.
Serena Vita *National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Via Portuense 292, 00149, Rome, Italy.
Dimitra KontogiannisNational Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Via Portuense 292, 00149, Rome, Italy. kontogiannis.dimitra@gmail.com.ORCID http://orcid.org/0009-0007-7378-1871
Tommaso Ascoli BartoliNational Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Via Portuense 292, 00149, Rome, Italy.
Silvia RosatiNational Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Via Portuense 292, 00149, Rome, Italy.
Nazario BevilacquaNational Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Via Portuense 292, 00149, Rome, Italy.
Gaetano MaffongelliNational Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Via Portuense 292, 00149, Rome, Italy.
Angela CorpolongoNational Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Via Portuense 292, 00149, Rome, Italy.
Barbara BartoliniNational Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Via Portuense 292, 00149, Rome, Italy.
Antonella VulcanoNational Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Via Portuense 292, 00149, Rome, Italy.
Alessandra D'AbramoNational Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Via Portuense 292, 00149, Rome, Italy.
Carla Fontana *National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Via Portuense 292, 00149, Rome, Italy.
Emanuele Nicastri *National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Via Portuense 292, 00149, Rome, Italy.
Mobile-INMI group

Funding

Ministero della Salute Linea 1- Malattie Infettive tropicali e neglette: aspetti patogenetici, immunologici e diagnostici
6 · The paper itself

Abstract

backgroundSub-Saharan African (SSA) migrants may carry asymptomatic Plasmodium infections after leaving endemic regions, potentially posing public health challenges in host countries. However, data on the prevalence and persistence of infection after migration are currently limited. The objective of this study is to assess the burden of asymptomatic malaria among adult SSA migrants attending an outpatient clinic in Rome.

methodsBetween February 2024 and January 2025, SSA migrants attending the Lazzaro Spallanzani Institute's mobile population clinic in Rome, Italy were screened for malaria using rapid diagnostic tests (RDTs), loop-mediated isothermal amplification (LAMP), thick smears, and real-time polymerase chain reaction (RT-PCR). Eligibility criteria included age ≥ 16, absence of fever, and origin or transit through malaria-endemic regions. Descriptive statistics were used to summarize epidemiological, clinical, and laboratory data. Continuous variables were expressed as means ± SD or median (IQR), and categorical variables as counts and percentages. A P-value < 0.05 was considered significant.

resultsAmong 87 asymptomatic migrants, malaria prevalence was 6%, all in male SSA migrants. One mixed infection was confirmed by microscopy. LAMP detected Plasmodium spp. in 5 cases (6.0%), confirmed by RT-PCR, while RDT identified only 2 (2.3%). Species identified by RT-PCR included P. falciparum, P. malariae, P. ovale, and one mixed infection. The longest time since arrival among positives was 181 days; including detention in Libya, the median interval since departure from endemic areas exceeded 600 days.

conclusionsAsymptomatic malaria can last for months after arrival and is often missed by RDTs. Incorporating RT-PCR diagnostics into routine screenings can improve early detection, lower local transmission risk, and enhance health outcomes.

Indexed as

Asymptomatic InfectionsMalariaTransients and MigrantsAdolescentAdultAfrica South of the SaharaAmbulatory Care FacilitiesFemaleHumansMaleMiddle AgedPlasmodiumPrevalenceRomeYoung AdultAsymptomatic malariaInfectious diseaseMigrant healthPlasmodiumScreeningSurveillance

Identifiers

PMID41126332
PMCPMC12548191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.